Bringing the fundamentals into focus…
Back to Axogen, Inc.
How Axogen, Inc. stacks up
AXGN · against 310 other Healthcare companies of similar size
Growth
65/ 100
Above the middle of the pack.
Ranked #120 of 311 · scores higher than 60% of peers
Bars: peers in each 10-point band of the growth score42 peers with a growth score of 60–69, including AXGN · Click a bar to see the companies
Why growth scores 65?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- The loss per share widened. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 80% of peers. 3-year revenue growth: 19.3% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 81% of peers. Revenue growth: 23.6% vs peer median 6.1%
Metric by metric
Position: dot = AXGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AXGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 310 reported | 23.6% | 7.2% | 78% | 33% | |
| Earnings per share growthHigher is better · 182 reported | Not reported | 11.3% | — | — | 33% |
| 3-year revenue growthHigher is better · 303 reported | 19.3% | 8.1% | 77% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around AXGN| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 116 | 1.7B USD | 66 | 30 | |
| 116 | 5.3B USD | 66 | 50 | |
| 116 | 1.7B USD | 66 | 33 | |
| 120 | 225.8B JPY (≈$1.5B) | 65 | 69 | |
| 120 | 2.9B USD | 65 | 44 | |
| 120 | 179.7B INR (≈$2.2B) | 65 | 74 | |
| 120 | 3.6B AUD (≈$2.4B) | 65 | 59 | |
| 120 | 2.0B USD | 65 | 29 | |
| 125 | 12.9B HKD (≈$1.7B) | 64 | 83 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score